Fight AIDS and Infectious Diseases Foundation, 08916 Badalona, Spain.
North Metropolitan Primary Care Directorate, Catalan Institute of Health, 08916 Badalona, Spain.
Int J Environ Res Public Health. 2021 Jul 3;18(13):7129. doi: 10.3390/ijerph18137129.
: The epidemiological situation generated by COVID-19 has cast into sharp relief the delicate balance between public health priorities and the economy, with businesses obliged to toe the line between employee health and continued production. In an effort to detect as many cases as possible, isolate contacts, cut transmission chains, and limit the spread of the virus in the workplace, mass testing strategies have been implemented in both public health and industrial contexts to minimize the risk of disruption in activity. : To evaluate the economic impact of the mass workplace testing strategy as carried out by a large automotive company in Catalonia in terms of health and healthcare resource savings. : Analysis of health costs and impacts based on the estimation of the mortality and morbidity avoided because of screening, and the resulting savings in healthcare costs. : The economic impact of the mass workplace testing strategies (using both PCR and RAT tests) was approximately €10.44 per test performed or €5575.49 per positive detected; 38% of this figure corresponds to savings derived from better use of health resources (hospital beds, ICU beds, and follow-up of infected cases), while the remaining 62% corresponds to improved health rates due to the avoided morbidity and mortality. In scenarios with higher positivity rates and a greater impact of the infection on health and the use of health resources, these results could be up to ten times higher (€130.24 per test performed or €69,565.59 per positive detected). : In the context of COVID-19, preventive actions carried out by the private sector to safeguard industrial production also have concomitant public benefits in the form of savings in healthcare costs. Thus, governmental bodies need to recognize the value of implementing such strategies in private settings and facilitate them through, for example, subsidies.
：COVID-19 疫情突显了公共卫生重点和经济之间的微妙平衡，企业必须在员工健康和持续生产之间走钢丝。为了尽可能多地发现病例，隔离接触者，切断传播链，并限制病毒在工作场所的传播，公共卫生和工业领域都实施了大规模检测策略，以最大限度地减少活动中断的风险。：评估大规模工作场所检测策略在加泰罗尼亚的一家大型汽车公司中的经济影响，就健康和医疗资源节省而言。：基于因筛查而避免的死亡率和发病率的估计，以及由此节省的医疗成本，对健康成本和影响进行分析。：大规模工作场所检测策略（使用 PCR 和 RAT 检测）的经济影响约为每次检测 10.44 欧元或每次阳性检测 5575.49 欧元；该数字的 38%对应于更好地利用卫生资源（医院床位、重症监护床位和感染病例的后续治疗）所带来的节省，而剩余的 62%对应于由于避免发病率和死亡率而改善的健康率。在阳性率更高且感染对健康和卫生资源利用的影响更大的情况下，这些结果可能高达十倍（每次检测 130.24 欧元或每次阳性检测 69565.59 欧元）。：在 COVID-19 背景下，私营部门为保障工业生产而采取的预防措施也会带来节省医疗成本等公共利益。因此，政府机构需要认识到在私人环境中实施此类策略的价值，并通过补贴等方式为其提供便利。
